Clinical Scorecard: Comprehensive Analysis: Approaches to Treating Non-Healing Wounds and Ongoing Perineal Sinuses After Proctectomy in Patients with Inflammatory Bowel Disease

At a Glance

Key Highlights

• Between 25-33% of patients with perianal Crohn’s disease have wounds unhealed by 12 months post-proctectomy.
• Unhealed wounds/PPS significantly impair quality of life due to symptoms like discharge, pain, and bleeding.
• No current clinical guidelines exist for treatment selection; evidence is limited and of very low certainty.

Guideline-Based Recommendations

Diagnosis

• Use accurate classification systems to guide treatment selection; TOpClass consortium classification for persistent symptoms post-proctectomy is recommended.
• Recognize unhealed wounds/PPS as a spectrum encompassing sinuses and delayed/non-healing wounds.

Management

• Consider advanced medical therapies, curettage, sinus excision, skin grafting, myocutaneous flap reconstruction, and hyperbaric oxygen therapy (HBOT).
• Treatment choice should be individualized due to anatomical complexity and lack of standardized guidelines.

Monitoring & Follow-up

• Monitor wound healing status at 6 and 12 months post-proctectomy to identify delayed or non-healing wounds.
• Assess symptom persistence and impact on quality of life regularly.

Risks

• Persistent wounds and PPS can lead to repeated hospitalizations and complications such as sacral osteomyelitis.
• Surgical interventions carry risks related to anatomical complexity and patient comorbidities.

Patient & Prescribing Data

Adults with Crohn’s disease or ulcerative colitis post-proctectomy developing unhealed wounds/PPS

Evidence from retrospective case series indicates variable healing rates; musculocutaneous flap interventions have very low certainty evidence supporting their effectiveness.

Clinical Best Practices

• Employ multidisciplinary teams including surgeons and gastroenterologists for comprehensive management.
• Use standardized definitions and classifications to improve communication and treatment planning.
• Prioritize symptom control and quality of life in treatment goals given the chronicity and complexity of unhealed wounds/PPS.
• Encourage further high-quality research to establish evidence-based treatment guidelines.

References

• PROSPERO Registration CRD42024622582
• NIH Quality Assessment Tool
• GRADEpro Guideline Development Tool